Lytix Biopharma appoints Stephen Worsley as Chief Business Officer - PR Newswire

Retrieved on: 2022-09-05 06:21:47

Tags for this article:

Click the tags to see associated articles and topics

Lytix Biopharma appoints Stephen Worsley as Chief Business Officer - PR Newswire. View article details on hiswai:

Excerpt

PRNewswire/ -- Lytix Biopharma ("Lytix") (Euronext Growth Oslo: LYTIX), a Norwegian immune-oncology company, today announces the appointment of ...

Article found on: www.prnewswire.com